Galkin Vladimir - Sep 19, 2024 Form 4/A - Amendment Insider Report for Innovative Eyewear Inc (LUCY)

Role
10%+ Owner
Signature
/s/ Vladimir Galkin, Attorney in Fact
Stock symbol
LUCY
Transactions as of
Sep 19, 2024
Transactions value $
$2,265,048
Form type
4/A - Amendment
Date filed
9/27/2024, 02:40 PM
Date Of Original Report
Sep 24, 2024
Previous filing
Sep 27, 2024
Next filing
Sep 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUCY Common Stock, par value $0.00001 Purchase $1.14M +125K +25.52% $9.15 613K Sep 19, 2024 See footnote F1, F2, F3
transaction LUCY Common Stock, par value $0.00001 Purchase $987K +110K +17.96% $8.97 723K Sep 19, 2024 See footnote F1, F3, F4
transaction LUCY Common Stock, par value $0.00001 Purchase $221K +25.6K +3.55% $8.62 748K Sep 19, 2024 See footnote F1, F3, F5
transaction LUCY Common Stock, par value $0.00001 Purchase $301K +37.2K +4.97% $8.10 786K Sep 19, 2024 See footnote F1, F3, F6
transaction LUCY Common Stock, par value $0.00001 Sale -$7.64K -780 -0.1% $9.79 785K Sep 19, 2024 See footnote F1, F3, F7
transaction LUCY Common Stock, par value $0.00001 Sale -$154K -16.2K -2.07% $9.50 769K Sep 19, 2024 See footnote F1, F3, F8
transaction LUCY Common Stock, par value $0.00001 Sale -$215K -24.4K -3.18% $8.79 744K Sep 19, 2024 See footnote F1, F3, F9
transaction LUCY Common Stock, par value $0.00001 Sale -$7.66K -901 -0.12% $8.50 743K Sep 19, 2024 See footnote F1, F3, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported reflects the volume weighted average purchase or sale price (whichever the case may be) on the transaction date within a $0.25 range, unless otherwise noted. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price within the ranges set forth in footnotes (2) and (4) to (10) in this Form 4.
F2 The purchases were executed in multiple trades at prices ranging from $9.01 to $9.20.
F3 The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") directly holds the shares of Common Stock. Angelica Galkin is the sole trustee and beneficiary of the Galkin Revocable Trust. Angelica Galkin has delegated to Vladimir Galkin the shared right to direct the voting and disposition of the securities owned by the Galkin Revocable Trust. Accordingly, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own the securities owned directly by Galkin Revocable Trust. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16") or for any other purpose.
F4 The purchases were executed in multiple trades at prices ranging from $8.76 to $9.00.
F5 The purchases were executed in multiple trades at prices ranging from $8.51 to $8.75.
F6 The purchases were executed in multiple trades at prices ranging from $8.10 to $8.27.
F7 The sales were executed in multiple trades at a price of $9.79.
F8 The sales were executed in multiple trades at a price of $9.50.
F9 The sales were executed in multiple trades at a price of $8.79.
F10 The sales were executed in multiple trades at a price of $8.50.

Remarks:

The original Form 4, filed on September 24, 2024, is being amended by this Form 4 amendment solely to include the omitted names and addresses of Angelica Galkin and The Angelica Galkin Revocable Trust as Reporting Persons, since they were unable to obtain the necessary CIK codes by the filing date. Notwithstanding the foregoing, the names and ownership information of such Reporting Persons were previously reported in the footnotes.